I read with great interest the paper of Chen and coworkers [1], who reported on the ‘relationship between a validated biomarker, intravenous midazolam clearance and the urinary cortisol ratio under constitutive conditions and with the influence of a moderate CYP3A inhibitior’ (p.1). The authors concluded that the ‘high intra-individual variability of the urinary cortisol ratio, compared with midazolam, makes this a suboptimal CYP3A phenotyping tool’ (p.1). A shortcoming may confound their results making the interpretation of their cortisol ratio difficult, if not impossible: the authors did not pay attention to a possible influence of varying urine volume. This criticism is based on the well-documented relationship between urine volume and urinary free cortisol excretion [2–8]. Unfortunately, the results of Chen et al. [1] would not be improved if results were reworked and the volume of each 24-h urine taken into calculation, since urinary steroid excretion depends also on daytime: an increase of urine volume in the morning (zenith of adrenocortical secretion [9]) will have a more pronounced effect on steroid excretion than a similar change of urine flow in the evening (nadir of adrenocortical secretion [9]). Conclusion: urinary free cortisol and probably of 6β-hydroxycortisol excretion in 24-h urines should be determined only if the urine volume is kept as constant as possible – this demands that patients or volunteers strictly observe their fluid intake (volume, daytime). Future work will then show that the ratio of urinary 6β-hydroxycortisol/cortisol can be used an index for CYP3A phenotyping.
References
- 1.Chen Y-C, Gotzkowsky SK, Nafziger AN, Kulawy RW, Rocci ML, Jr, Bertino JS, Jr, Kashuba ADM. Poor correlation between 6β-hydroxycortisol:cortisol molar ratios and midazolam clearance as measure of hepatic CYP3A activity. Br J Clin Pharmacol. 2006;62:187–95. doi: 10.1111/j.1365-2125.2006.02628.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Baum CK, Davison MJ, Landon J. Urinary free cortisol by normal individuals. J Endocrinol. 1974;63:47P–48P. [PubMed] [Google Scholar]
- 3.Lundberg U, Forsman L. Consistency in catecholamine and cortisol excretion patterns over experimental conditions. Pharmacol Biochem Behav. 1980;12:449–52. doi: 10.1016/0091-3057(80)90052-0. [DOI] [PubMed] [Google Scholar]
- 4.Wambach G, Bleienheuft C, Börner G. Sodium loading raises urinary cortisol in man. J Endocrinol Invest. 1986;9:257–9. doi: 10.1007/BF03348113. [DOI] [PubMed] [Google Scholar]
- 5.Gutenbrunner C, Schreiber U. Circadian variations of urine excretion and adrenocortical function in different states of hydration in man. Progr Clin Biol Res. 1987;227A:309–15. [PubMed] [Google Scholar]
- 6.Birmingham MK, Barta A, Solyom L, Lehoux JG, Vescei P. Correlation between mood scores, LH, adrenocortical steroids, and urine volumes in a patient with a history of postpartum depression and monthly psychotic episodes. Endocr Res. 1998;24:595–9. doi: 10.3109/07435809809032652. [DOI] [PubMed] [Google Scholar]
- 7.Friedman TC, Papanicolaou DA. Comment on high urinary free cortisol excretion in a patient with psychogenic polydipsia. J Clin Endocrinol Metab. 1998;83:3378. doi: 10.1210/jcem.83.9.5100-2. [DOI] [PubMed] [Google Scholar]
- 8.Mericq MV, Cutler GB., Jr High fluid intake increases urine free cortisol excretion in normal subjects. J Clin Endocrinol Metab. 1998;83:682–4. doi: 10.1210/jcem.83.2.4555. [DOI] [PubMed] [Google Scholar]
- 9.Morineau G, Boudi A, Barka A, Gourmelen M, Degeilh F, Hardy N, Al-Haknak A, Soliman H, Gosling JP, Julien R, Brerault JL, Boudou P, Aubert P, Villette J-M, Pruna A, Galons H, Fiet J. Radioimmunoassay of cortisone in serum, urine, and saliva to assess the status of the cortisol–cortisone shuttle. Clin Chem. 1997;43:786–93. [PubMed] [Google Scholar]